Logos Capital
About Logos Capital
Logos Capital is a fundamental biotechnology-focused investment fund.
Investment focus
Stages
Sectors
Portfolio (3 in our database)
Odyssey TherapeuticsOdyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.Series A · $218M raisedParse BiosciencesParse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.Series B · $50M raisedGennao BioGennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.Series A · $41M raised